Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron for Anterior Resection Syndrome
NCT02869984Phase 1Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ramosetron in low anterior resection syndrome (LARS) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Proportion of patients with major Low Anterior Resection Syndrome at 4 weeks. Status: unknown.
02
Drugs
ramosetron
03
Conditions
low anterior resection syndrome (LARS)
Beyond the preview
Go deeper on NCT02869984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02869984.